These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6358202)

  • 1. Isolation and purification of morphogenic autoregulatory substance produced by Candida albicans.
    Hazen KC; Cutler JE
    J Biochem; 1983 Sep; 94(3):777-83. PubMed ID: 6358202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of an autoregulatory substance capable of regulating the morphological transition in Candida albicans.
    Oh KB; Miyazawa H; Naito T; Matsuoka H
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4664-8. PubMed ID: 11274356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.
    Hornby JM; Jensen EC; Lisec AD; Tasto JJ; Jahnke B; Shoemaker R; Dussault P; Nickerson KW
    Appl Environ Microbiol; 2001 Jul; 67(7):2982-92. PubMed ID: 11425711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans.
    Lee KL; Buckley HR; Campbell CC
    Sabouraudia; 1975 Jul; 13(2):148-53. PubMed ID: 808868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimorphism-associated variations in the lipid composition of Candida albicans.
    Ghannoum MA; Janini G; Khamis L; Radwan SS
    J Gen Microbiol; 1986 Aug; 132(8):2367-75. PubMed ID: 3540201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of polar lipids from yeast and mycelial forms of Candida albicans and Candida dubliniensis.
    Mahmoudabadi AZ; Drucker DB
    Mycoses; 2006 Jan; 49(1):18-22. PubMed ID: 16367813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exo-1,3-beta-glucanase activity in Candida albicans: effect of the yeast-to-mycelium transition.
    Molina M; Cenamor R; Nombela C
    J Gen Microbiol; 1987 Mar; 133(3):609-17. PubMed ID: 3116163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase D activity is required for dimorphic transition in Candida albicans.
    McLain N; Dolan JW
    Microbiology (Reading); 1997 Nov; 143 ( Pt 11)():3521-3526. PubMed ID: 9387230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of salivary components that induce transition of hyphae to yeast in Candida albicans.
    Leito JT; Ligtenberg AJ; Nazmi K; Veerman EC
    FEMS Yeast Res; 2009 Oct; 9(7):1102-10. PubMed ID: 19799638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial invasion outcompetes hypha development during Candida albicans infection as revealed by an image-based systems biology approach.
    Mech F; Wilson D; Lehnert T; Hube B; Thilo Figge M
    Cytometry A; 2014 Feb; 85(2):126-39. PubMed ID: 24259441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans.
    Burnie JP; Matthews RC; Fox A; Tabaqchali S
    J Clin Pathol; 1985 Jun; 38(6):701-6. PubMed ID: 3891792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some factors affecting the transformation of the yeast-like to the mycelial-like forms of Candida albicans.
    Ton SH; Karunairatnam MC
    Southeast Asian J Trop Med Public Health; 1976 Mar; (1):72-6. PubMed ID: 800285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs.
    Dumitru R; Hornby JM; Nickerson KW
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2350-4. PubMed ID: 15215080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of hydrophobic and hydrophilic variants of Candida albicans.
    Hazen BW; Hazen KC
    FEMS Microbiol Lett; 1989 Jan; 48(2):167-71. PubMed ID: 2656379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ tube growth of Candida albicans.
    Gow NA
    Curr Top Med Mycol; 1997 Dec; 8(1-2):43-55. PubMed ID: 9504066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyl-D-glucosamine-induced morphogenesis in Candida albicans.
    Cassone A; Sullivan PA; Shepherd MG
    Microbiologica; 1985 Jan; 8(1):85-99. PubMed ID: 3883103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosol is a quorum-sensing molecule in Candida albicans.
    Chen H; Fujita M; Feng Q; Clardy J; Fink GR
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):5048-52. PubMed ID: 15051880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth kinetics and morphology of colonies of the filamentous form of Candida albicans.
    Gow NA; Gooday GW
    J Gen Microbiol; 1982 Sep; 128(9):2187-94. PubMed ID: 6757383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer.
    Naidu AS; Chen J; Martinez C; Tulpinski J; Pal BK; Fowler RS
    J Reprod Med; 2004 Nov; 49(11):859-66. PubMed ID: 15603095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the dimorphic transition of Candida albicans by the ornithine decarboxylase inhibitor 1,4-diaminobutanone: alterations in the glycoprotein composition of the cell wall.
    Martinez JP; Lopez-Ribot JL; Gil ML; Sentandreu R; Ruiz-Herrera J
    J Gen Microbiol; 1990 Oct; 136(10):1937-43. PubMed ID: 2269870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.